GE Healthcare Life Sciences Announces KUBio Modular Biopharmaceutical Factory to be Built in China for JHL Biotech

GE Healthcare Life Sciences, a business unit of GE Healthcare

, and JHL Biotech, a provider of biopharmaceutical process development and manufacturing services, today announced that a KUBio™ modular biopharmaceutical factory will be built in China for JHL Biotech. The site for the new factory, which will be fully operational beginning early 2015, is the Biolake Science Park in Wuhan, China. GE Healthcare's KUBio™ modular biopharmaceutical factory (Photo: Business Wire) Worldwide demand for biopharmaceuticals, such as antibodies for the treatment of cancer and a new generation of innovative vaccines, is increasing dramatically. KUBio is a new approach to readily establish biopharmaceutical manufacturing capacity by delivering customers a fully